Title
|
Methods of Estimation for Censored Data
|
Date / Time / Room
|
Sponsor
|
Type
|
08/12/2002
8:30 AM -
10:20 AM
Room: H-Nassau Suite A
|
Biometrics Section*, Biopharmaceutical Section*, ENAR
|
Contributed
|
Organizer:
|
n/a
|
Chair:
|
Robb Muirhead, Pfizer Global R&D
|
Discussant:
|
|
Description
When censoring is independent of the outcome, it is relatively benign, but when censoring value and outcome are dependent-as commonly occurs with cost data-modeling is more complex. This session will consider methods for estimation when the outcomes-including survival and costs-are subject to censoring.
|
|